Pediatric Neurology

Latest News

Clinicians Not Adhering to AAP Guidelines for Developmental Disorder Screening

Although the American Academy of Pediatrics has published thorough guidelines and recommendations for screening for developmental disorders, many clinicians have not incorporated screening into routine well visits.

Subclinical Hypothyroidism, LT4 Treatment Do Not Affect Cognitive Function in Children

Neurocognitive function in children is unimpaired by persistent idiopathic subclinical hypothyroidism and is not affected by levothyroxine supplementation.

Age of Onset May Affect Clinical Outcomes for Patients With Multiple Sclerosis on DMT

Age-dependent differences seen for clinical outcomes in response to disease-modifying therapy.

Intranasal Ketamine Reduces Pain in Children Hospitalized for Migraine

A single-center study showed that intranasal ketamine effectively reduced pain in children with migraine from hospital admission to discharge.

Use of Developmental Screening Tools Increasing Among Pediatricians

From 2002 to 2016, there was an increase in pediatricians’ reported use of developmental screening tools and in referral of at-risk patients for early intervention (EI)

Greater Emphasis is Needed on Sleep Medicine for Child Neurology Trainees

Researchers report the need for more child neurology trainees to enter a sleep medicine fellowship in an effort to improve the outcomes of children with neurologic disorders that may be linked to sleep disruption.

Brain Structure and Function Become Coupled During Cognitive Maturation in Adolescents

A neuroimaging study has identified network-level plasticity mechanisms involved in cognitive maturation during adolescence and into adulthood.

Gene Therapy for Mucopolysaccharidosis Type IIIA Gets Fast Track Designation

The Food and Drug Administration (FDA) has granted Fast Track designation to LYS-SAF302 (Lysogene), an investigational gene therapy for the treatment of mucopolysaccharidosis Type IIIA (MPS IIIA).

New Pediatric Multiple Sclerosis Therapies More Effective Than Injectables

Using newer disease-modifying therapies for the initial treatment of pediatric multiple sclerosis may be more effective than injectables at controlling disease activity.

Test for Fragile X Syndrome Screening, Diagnosis Gets FDA Clearance

A diagnostic test for fragile X syndrome (FXS) has been cleared by the Food and Drug Administration.